Bluher M, Mantzoros CS. From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism 2015;64:131–45.Google Scholar
Park J, Morley TS, Kim M, Clegg DJ, Scherer PE. Obesity and cancer--mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol 2014;10:455–65.Google Scholar
Liu YL, Liang HR, Liu HT, Li SY, Zhou YY, et al. Association of serum adiponectin levels with artherosclerosis and the metabolic syndrome in obese children. J Pediatr Endocrinol Metab 2010;23:743–51.Google Scholar
Schipper HS, Nuboer R, Prop S, van den Ham HJ, de Boer FK, et al. Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14++ monocytes. Diabetologia 2012;55:2800–10.Google Scholar
Landgraf K, Friebe D, Ullrich T, Kratzsch J, Dittrich K, et al. Chemerin as a mediator between obesity and vascular inflammation in children. J Clin Endocrinol Metab 2012;97:E556–64.Google Scholar
Yamawaki H, Kameshima S, Usui T, Okada M, Hara Y. A novel adipocytokine, chemerin exerts anti-inflammatory roles in human vascular endothelial cells. Biochem Biophys Res Commun 2012;423:152–7.Google Scholar
Feng X, Li P, Zhou C, Jia X, Kang J. Elevated levels of serum chemerin in patients with obstructive sleep apnea syndrome. Biomarkers 2012;17:248–53.Google Scholar
Maghsoudi Z, Kelishadi R, Hosseinzadeh-Attar MJ. The comparison of chemerin, adiponectin and lipid profile indices in obese and non-obese adolescents. Diabetes Metab Syndr 2016;10(2 Suppl 1):S43–6.Google Scholar
Maghsoudi Z, Kelishadi R, Hosseinzadeh-Attar MJ. Association of chemerin levels with anthropometric indexes and C-reactive protein in obese and non-obese adolescents. ARYA Atheroscler 2015;11(Suppl 1):102–8.Google Scholar
Hwang HJ, Jung TW, Hong HC, Choi HY, Seo JA, et al. Progranulin protects vascular endothelium against atherosclerotic inflammatory reaction via Akt/eNOS and nuclear factor-kappaB pathways. PLoS One 2013;8:e76679.Google Scholar
Qu H, Deng H, Hu Z. Plasma progranulin concentrations are increased in patients with type 2 diabetes and obesity and correlated with insulin resistance. Mediators Inflamm 2013;2013:360190.Google Scholar
Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007;148:4687–94.Google Scholar
Youn BS, Bang SI, Kloting N, Park JW, Lee N, et al. Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes 2009;58:627–36.Google Scholar
Quante M, Hesse M, Dohnert M, Fuchs M, Hirsch C, et al. The LIFE child study: a life course approach to disease and health. BMC Public Health 2012;12:1021.Google Scholar
Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiß HC, et al. Perzentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001;149:807–18.Google Scholar
Reinehr T, Holl RW, Wabitsch M. The German Working Group of Obesity in Childhood and Adolescence (AGA): improving the quality of care for overweight and obese children in Germany. Obes Facts 2008;1:26–32.Google Scholar
Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. deliberations of the sleep apnea definitions task force of the American academy of sleep medicine. J Clin Sleep Med 2012;8:597–619.Google Scholar
Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29–36.Google Scholar
Al-Ayadhi LY, Mostafa GA. Low plasma progranulin levels in children with autism. J Neuroinflammation 2011;8:111.Google Scholar
Ismail N, Ragab S, Abd El Baky A, Hamed M. Relation between serum progranulin, inflammatory markers and visceral fat in childhood obesity. Adv Biosci Biotechnol 2013;4:1030–8.Google Scholar
Wagner IV, Sabin MA, Pfaffle RW, Hiemisch A, Sergeyev E, et al. Effects of obesity on human sexual development. Nat Rev Endocrinol 2012;8:246–54.Google Scholar
Kiess W, Muller G, Galler A, Reich A, Deutscher J, et al. Body fat mass, leptin and puberty. J Pediatr Endocrinol Metab 2000;13(Suppl 1):717–22.Google Scholar
Zeinoaldini S, Swarts JJ, Van de Heijning BJ. A signaling role for leptin in puberty onset in female rats? J Pediatr Endocrinol Metab 2006;19:1239–47.Google Scholar
Bottner A, Kratzsch J, Muller G, Kapellen TM, Bluher S, et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 2004;89:4053–61.Google Scholar
Olson CA, Hamilton NA, Somers VK. Percentage of REM sleep is associated with overnight change in leptin. J Sleep Res 2016;25:419–25.Google Scholar
Chamberland JP, Berman RL, Aronis KN, Mantzoros CS. Chemerin is expressed mainly in pancreas and liver, is regulated by energy deprivation, and lacks day/night variation in humans. Eur J Endocrinol 2013;169:453–62.Google Scholar
Fogteloo AJ, Pijl H, Roelfsema F, Frolich M, Meinders AE. Impact of meal timing and frequency on the twenty-four-hour leptin rhythm. Horm Res 2004;62:71–8.Google Scholar
Lakhdar N, Ben Saad H, Denguezli M, Zaouali M, Zbidi A, et al. Effects of intense cycling training on plasma leptin and adiponectin and its relation to insulin resistance. Neuro Endocrinol Lett 2013;34:229–35.Google Scholar
Larson-Meyer DE, Palm S, Bansal A, Austin KJ, Hart AM, et al. Influence of running and walking on hormonal regulators of appetite in women. J Obes 2012;2012:15.Google Scholar
About the article
Published Online: 2016-12-10
Published in Print: 2017-01-01
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This work was supported by the German Diabetes Association and by the German Federal Ministry of Education and Research (IFB and Competence Network Adiposity). LIFE is funded by the European Union, by the European Regional Development Fund and by means of the Free State of Saxony within the framework of the excellence initiative.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report or in the decision to submit the report for publication.